Open AccessJournal Article
Long-term survival.
Cho Yw,Terasaki Pi +1 more
TLDR
In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year, and for patients receiving kidneys with no HLA-A,B mismatches, the average half- life was 10.1 years.Abstract:
1. In transplants performed between 1971 and 1986, first cadaver donor grafts had a half-life ranging from 6.6 to 7.5 years in the period after the first year. Second cadaver donor grafts had a half-life of 5.1 to 6.5 years. Parental donor grafts had a half-life of 9.3 to 11.8 years, whereas HLA identical sibling donor transplants had a half-life of 19.1 to 26.5 years. Siblings with no haplotype in common had an average half-life of 8.7 years. 2. Between 1971 and 1984, white recipients had an average half-life of 7.7 years, which increased to 9.3 years in 1985-1986. Black recipients' half-life decreased from 5.4 years in 1975-1976 to 3.5 years in 1985-1986. The reason for this decrease is not apparent. 3. The half-life of transplants of different recipient ages did not vary significantly. The average half-life during this period of study was 7.4 years for those younger than 21 years of age, 8.2 years for recipients 21 to 50 and 6.7 years for those older than 50. 4. In the early data, there was some evidence that the half-life of kidneys with cold ischemia below 13 hours was superior. However, in the latest period (between 1983 and 1986) the average half-life was 7.6 years for CIT below 13 hours, 7.2 years for those with 13 to 24 hours and 6.4 years for more than 24 hours. 5. For patients receiving kidneys with no HLA-A,B mismatches, the average half-life was 10.1 years. Those with A,B mismatches had a half-life of 6.7 years, and for those with no A,B antigens in common, the average half-life was 6 years. 6. In the period after 1981, the average half-life of patients with no A,B,DR mismatches was 9.1 years compared with 6.5 years for those with A,B,DR mismatches and 5.4 years for those with no A,B,DR antigens in common.read more
Citations
More filters
Dissertation
Interactions of Mycobacterium bovis with protozoa and the occurrence of Mycobacterium bovis in environmental protozoa
TL;DR: Findings suggest that A. castellanii contributes to the decrease of M. bovis and therefore, it can be suggested that protozoa might have a negative impact on the survival M.bovis in the environment.
Socioeconomic impact of cervical spinal cord injury operated in patients with lower income group
TL;DR: Cervical spine surgery alone does not make sure of a good functional outcome for the patients of spinal cord injury, hence socieconomic status of an individual, possibility/ availability of rehabilitation program should be kept in mind to predict/ prognosticate the outcome.
Journal ArticleDOI
Omi, a recessive mutation on chromosome 10, is a novel allele of Ostm1.
Erika A. Bosman,Jeanne Estabel,Ozama Ismail,Christine Podrini,Jacqueline K. White,Karen P. Steel +5 more
TL;DR: The initial characterization and mapping of a recessive mutation that leads to degeneration of the incisors, failure of molars to erupt, a grey coat colour, and mild osteopetrosis is described and proposed that omi is a novel hypomorphic mutation affecting Ostm1 expression, potentially in a regulatory element.
Dissertation
Identification and validation of potential targets for the diagnosis and therapy of chronic lymphocytic leukaemia
TL;DR: It is found that dopamine and D2 antagonist domperidone reduced CLL cell survival in vitro, in a dose dependent manner, and these novel molecules provide several potential untested therapeutic targets in CLL.
Journal ArticleDOI
Surgical considerations for elderly urologic oncology patients
TL;DR: It is found in multiple series that well selected, elderly patients can safely undergo major, extirpative urologic surgery with acceptable morbidity, comparable to their younger counterparts.